ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,521.52
-1.39%
Dow Jones
40,813.57
-1.30%
US Dollar vs MXN
20.10616
0.10%
Brent Oil
70.085
0.23%
Bitcoin
81,939.05
1.11%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Gossamer Bio Inc (GOSS)

  7. Gossamer Bio Inc (GOSS) Noticias

GOSS

Gossamer Bio (GOSS)

Gossamer Bio Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:GOSS
FechaHoraFuenteTítuloSímboloCompañía
13/03/202515:03Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:GOSSGossamer Bio Inc
13/03/202515:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOSSGossamer Bio Inc
13/03/202515:01Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:GOSSGossamer Bio Inc
06/03/202515:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GOSSGossamer Bio Inc
12/02/202515:30Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:GOSSGossamer Bio Inc
07/02/202516:30Business WireGossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GOSSGossamer Bio Inc
05/02/202517:28Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:GOSSGossamer Bio Inc
03/02/202506:01Business WireGossamer Bio Presented Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual CongressNASDAQ:GOSSGossamer Bio Inc
28/01/202506:01Business WireGossamer Bio to Present Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual CongressNASDAQ:GOSSGossamer Bio Inc
12/11/202415:40Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:GOSSGossamer Bio Inc
07/11/202415:03Business WireGossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:GOSSGossamer Bio Inc
07/11/202415:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GOSSGossamer Bio Inc
26/08/202415:01Business WireGossamer Bio Announces Data Presentations at the European Respiratory Society Congress 2024NASDAQ:GOSSGossamer Bio Inc
12/08/202415:01Business WireGossamer Bio Announces Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:GOSSGossamer Bio Inc
14/05/202415:01Business WireGossamer Bio to Provide Updated Seralutinib TORREY Open-Label Extension Data at the American Thoracic Society 2024 International ConferenceNASDAQ:GOSSGossamer Bio Inc
07/05/202415:01Business WireGossamer Bio Announces First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:GOSSGossamer Bio Inc
06/05/202406:30Business WireGossamer Bio and Chiesi Group Announce Transformative Global Collaboration to Develop and Commercialize Seralutinib in PAH, PH-ILD & Other IndicationsNASDAQ:GOSSGossamer Bio Inc
03/05/202407:02Business WireGossamer Bio Announces Publication of TORREY Phase 2 Results in the Lancet Respiratory MedicineNASDAQ:GOSSGossamer Bio Inc
12/03/202406:31Business WireGossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan to its Board of DirectorsNASDAQ:GOSSGossamer Bio Inc
05/03/202406:31Business WireGossamer Bio Announces Fourth Quarter and Full-Year 2023 Financial Results and Provides Business UpdateNASDAQ:GOSSGossamer Bio Inc
13/12/202315:01Business WireGossamer Bio to Host Webcast to Discuss Latest Seralutinib Open-Label Extension Data on December 18, 2023NASDAQ:GOSSGossamer Bio Inc
05/12/202316:09Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:GOSSGossamer Bio Inc
05/12/202306:01Business WireGossamer Bio Appoints Bob Smith as Chief Commercial OfficerNASDAQ:GOSSGossamer Bio Inc
29/11/202306:01Business WireGossamer Bio Announces Appointment of John Quisel, J.D., Ph.D., to its Board of DirectorsNASDAQ:GOSSGossamer Bio Inc
09/11/202306:31Business WireGossamer Bio Announces Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:GOSSGossamer Bio Inc
03/10/202315:08Business WireGossamer Bio Announces Addition of Rainer Zimmermann, MD, as VP of Medical AffairsNASDAQ:GOSSGossamer Bio Inc
07/09/202306:44Business WireGossamer Bio to Present Results of TORREY FRI Sub-Study at the European Respiratory Society International Congress 2023NASDAQ:GOSSGossamer Bio Inc
28/08/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GOSSGossamer Bio Inc
28/08/202315:29Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:GOSSGossamer Bio Inc
21/08/202315:01Edgar (US Regulatory)Form DEL AM - Delaying amendmentNASDAQ:GOSSGossamer Bio Inc
 Showing the most relevant articles for your search:NASDAQ:GOSS

Su Consulta Reciente

AMEX
MEK
Metretek
TSXV
JG
Japan Gold
AMEX
XLY
Consumer Discretionary S...
LSE
SEG
Sci Entertainment
BFNX
XRPUSD
Ripple
USOTC
DOMWF
Prime Drink (PK)
NASDAQ
BNTCW
Benitec Biopharma
USOTC
DPZUF
Dominos Pizza Australia ... (PK)
AQSE
SEE.GB
Seeing Machines
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios